Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels.

Literature DB >> 17322514

Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels.

Michelle M Kittleson, Marcus E St John, Valeriani Bead, Hunter C Champion, Edward K Kasper, Stuart D Russell, Ilan S Wittstein, Joshua M Hare.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2007 PMID： 17322514 PMCID： PMC1861450 DOI： 10.1136/hrt.2006.090845

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

× No keyword cloud information.

5 in total

1. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.

Authors: W Doehner; M Rauchhaus; V G Florea; R Sharma; A P Bolger; C H Davos; A J Coats; S D Anker
Journal: Am Heart J Date: 2001-05 Impact factor: 4.749

2. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.

Authors: Stefan D Anker; Wolfram Doehner; Mathias Rauchhaus; Rakesh Sharma; Darrel Francis; Christoph Knosalla; Constantinos H Davos; Mariantonietta Cicoira; Waqar Shamim; Michel Kemp; Robert Segal; Karl Josef Osterziel; Francisco Leyva; Roland Hetzer; Piotr Ponikowski; Andrew J S Coats
Journal: Circulation Date: 2003-04-21 Impact factor: 29.690

3. Biochemical detection of left-ventricular systolic dysfunction.

Authors: T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal: Lancet Date: 1998-01-03 Impact factor: 79.321

4. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy.

Authors: T P Cappola; D A Kass; G S Nelson; R D Berger; G O Rosas; Z A Kobeissi; E Marbán; J M Hare
Journal: Circulation Date: 2001-11-13 Impact factor: 29.690

5. The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors: Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal: Circulation Date: 2006-03-13 Impact factor: 29.690

5 in total

10 in total

1. The relationship between serum levels of uric acid and prognosis of infection in critically ill patients.

Authors: He-Chen Zhu; Ruo-Lan Cao
Journal: World J Emerg Med Date: 2012

2. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.

Authors: Michael M Givertz; Kevin J Anstrom; Margaret M Redfield; Anita Deswal; Haissam Haddad; Javed Butler; W H Wilson Tang; Mark E Dunlap; Martin M LeWinter; Douglas L Mann; G Michael Felker; Christopher M O'Connor; Steven R Goldsmith; Elizabeth O Ofili; Mitchell T Saltzberg; Kenneth B Margulies; Thomas P Cappola; Marvin A Konstam; Marc J Semigran; Steven E McNulty; Kerry L Lee; Monica R Shah; Adrian F Hernandez
Journal: Circulation Date: 2015-04-14 Impact factor: 29.690

10. Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.

Authors: Claudio Borghi; Stefano Omboni; Giorgio Reggiardo; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
Journal: BMC Cardiovasc Disord Date: 2018-06-05 Impact factor: 2.298

10 in total

Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels.

1. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.

2. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.

3. Biochemical detection of left-ventricular systolic dysfunction.

4. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy.

5. The Seattle Heart Failure Model: prediction of survival in heart failure.

1. The relationship between serum levels of uric acid and prognosis of infection in critically ill patients.

2. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.

3. Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study.

4. Transcriptomic biomarkers for individual risk assessment in new-onset heart failure.

5. Hyperuricemia and incident heart failure.

Review 6. Uric acid in heart failure: a biomarker or therapeutic target?

7. Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology.

8. Malondialdehyde and Uric Acid as Predictors of Adverse Outcome in Patients with Chronic Heart Failure.

Review 9. Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance.

10. Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.